Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
Objective: To review and discuss key aspects of the drug therapy recommendations in the American College of Cardiology (ACC)/American Heart Association (AHA) 2005 Guideline Update for the ...
Drugs from Ionis and Arrowhead Pharma that block ... and ultra-rare disorder familial chylomicronaemia syndrome (FCS). At ACC, Ionis reported results from the phase 3 BALANCE trial of its ...
ACC received a claim from Tauranga Hospital ... PET scan confirmed he had metastatic Stage 4 terminal cancer. He said medication was “keeping me alive”, but if it stops working he may have ...
Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
While the ACC/AHA 2005 Guideline Update [1] does not fully differentiate between aldosterone antagonist drugs, current data are insufficient to assume equivalence and similar benefit:risk ratios.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback